(which wasn't always clear to me before since I initially predicted that this will take years to work out)
All of these numbers are inline with what experts have been saying and modeling for more than a month. We will be dealing with this for at least another year. We will cycle through policy to loosen up and close back down a little. In the best case for NYC they are 1/4th of the way to herd immunity in numbers. With the drop in transmissions, this might be 1/8th of the way in terms of time. There will be more deaths in the future than have been recorded so far.
Look for the bright side in things, but zero cases is a pipe dream.
With most endemic viruses, antibody incidence is somewhere around 30-50% I believe, but I haven't seen any modelling for what covid is expected to do specifically.
The CDC reports that flu has an IFR of ~.13% in the US (61,000 deaths out of 45 million cases). That makes 0.5% roughly 3.3 times worse, not 10.
Also, herd immunity does not require 100% having positive antibodies, it will show an effect on Ro starting around 65%.
that's not what herd immunity means, unless we isolate those spreaders so they don't get in touch with "non-spreaders"
I think they're saying that people who go out and spread the disease will quickly catch it, recover, and be unable to catch it and spread it. That relatively small group of people who are refusing to self isolate, will gain herd immunity, causing the virus to die out in that group of people, preventing them from giving it to the non-spreaders that have been at home the whole time.
Whether or not it will work out that way, I don't know.
You can also do a separate phone survey in addition to surveying the test participants. Questions like "Do you think you have had COVID?" and "How many times per week do you leave the house?". If the responses for the test participants vary significantly from the phone survey participants, you can try and weight your data accordingly.
There's also literature that suggests that you don't discard outlier values in the actual responders as they may help approximate the non-responder population, i.e., the non-outliers represent typical responders while outliers are more likely to represent non-responders [1]
[0]https://www.warc.com/content/paywall/article/jar/research_no...
[1] https://bmcmedresmethodol.biomedcentral.com/articles/10.1186...
f(N, P): (1 - ((1-P)^N)) / P
For a large P you're right, but as P gets very small (let's say that in any given trip you have a 0.01% chance of being sampled) then the increase in likelihood of being sampled approaches N times as much (in this example, it would be 6.999 times as likely). Of course, this assumes they're taking measures to ensure no one gets sampled twice.
This sampling would have a (possibly slight, but still unknown) bias towards people who are isolating less (who you would expect to then have a higher than average percent positive for antibodies, assuming isolating is helpful).
I don't think anyone knows whether or not this is a more representative sample than the stanford study.